GPCR VideoCast << Back to VideoCast list Dr. David Sykes About Dr. David has over 20+ years of experience working in a drug discovery environment mainly in a specialist During this period David has made a significant contribution to the understanding of agonist/ antagonist GPCR current interests include the development of HTS fluorescence-based kinetic binding assays specifically designed GPCR Listen and subscribe where you get your podcasts Tags ​ << Previous VideoCast Episode Next VideoCast

GPCR Podcast << Back to podcast list Dr. GPCR Board About this episode Fiona Marshall got fascinated with GPCRs after attending a lecture on how An expert in GPCR biology, Fiona published the first description of the cloning and structural requirements As a co-founder of Heptares Therapeutics , now called Sosei Heptares , a GPCR-focused drug discovery stabilization and structure-based drug design.

Retreat 2023 About Program Registration Logo Contest Committee Sponsors Logo Contest Introducing the GPCR Retreat Logo Contest In anticipation of the next GPCR Retreat, we are delighted to announce the GPCR The organizers, including the GPCR retreat founders Dr. Stephen Ferguson and Dr. The winning logo designer will receive well-deserved recognition and a cash prize of $250. Transmembranaires du Québec 22nd GPCR Retreat Sponsored by

< GPCR News < GPCRs in Oncology and Immunology GPCR signaling contributes to immune characteristics of News Coming soon Become a Contributor Classified GPCR News Call for GPCR papers GPCR Industry News Adhesion GPCRs GPCR Events, Meetings, and Webinars Reviews, GPCRs, and more GPCR Binders, Drugs, and more Methods & Updates in GPCR Research GPCRs in Neuroscience GPCRs in Cardiology, Endocrinology, and Taste GPCRs GPCR News and get weekly notifications about the GPCR field Share < Previous Next >

GPCR Podcast << Back to podcast list Dr. GPCR Board About Dr. self-sustaining computational chemistry service provider, developing its own software for application in various drug I have extensive training in computer-aided drug design. training as a chemist and as an entrepreneur to grow a sustainable service and software provider in drug GPCR Listen and subscribe where you get your podcasts << Previous Podcast Episode Next Podcast Episode

GPCR VideoCast << Back to VideoCast list Dr. Fiona Marshall About this episode Fiona Marshall got fascinated with GPCRs after attending a lecture As a co-founder of Heptares Therapeutics , now called Sosei Heptares , a GPCR-focused drug discovery stabilization and structure-based drug design. GPCR Ecosystem Listen and subscribe where you get your podcasts Tags ​ << Previous VideoCast Episode

GPCR at the Great Lakes GPCR Retreat : We'd like to thank the organizers for a great meeting! GPCR will be collaborating with the organizers of the GPCR Retreat 2023, which will be held in October GPCR has affected you and the field today . GPCR News 1. Quantitative live-cell imaging of GPCR downstream signaling dynamics. 1.7 GPCR Binders, Drugs, and More Targets for Drug Discovery AcroScreen co-founder Margaux Duchamp has been selected as a 30 under 30

< GPCR News < GPCRs in Oncology and Immunology G protein-coupled estrogen receptor (GPER)/GPR30 forms Coming soon Become a Contributor Classified GPCR News Call for GPCR papers GPCR Industry News Adhesion GPCRs GPCR Events, Meetings, and Webinars Reviews, GPCRs, and more GPCR Binders, Drugs, and more Methods & Updates in GPCR Research GPCRs in Neuroscience GPCRs in Cardiology, Endocrinology, and Taste GPCRs GPCR News and get weekly notifications about the GPCR field Share < Previous Next >

GPCR Brand Features. Your use of the Dr. GPCR Brand Features will inure to the benefit of Dr. GPCR. GPCR development of Dr. GPCR Buttons. By using a Dr. GPCR button, Publishers give Dr. Buttons And Badges Guideline ​ These guidelines provide you with the design specification for various GPCR Logo in different marketing materials, such as: a new T-shirt design, a toy, software packaging, These trademarks include the Logo, Buttons, Badges, Website Design and other pictures and graphic designs

GPCR: Dr. GPCR Podcast : This month marks the 1 year anniversary of the podcast! GPCR Virtual Cafe episodes and more. Did you know you can also become a Dr. GPCR Member ? dimers in living cells Psychedelic-inspired drug discovery using an engineered biosensor A genetically signaling G-Protein Peptidomimetics Stabilize GPCR Active State Conformations Oliceridine: A Novel Drug for Enterprise in Innovation SoftBank leads funding that could net up to $525M for Exscientia's AI drug

Retreat 2023 About Program Registration Logo Contest Committee Sponsors GPCR Retreat The GPCR Retreat focuses on advances in our understanding of how GPCRs operate in cell communication. The main goal of the GPCR Retreat is to provide a venue for students, post-doctoral fellows, and principal Registration to the GPCR Retreat is capped at 200 participants to promote an intimate environment. in the Ottawa 2017 edition, to showcase the breadth of diversity in GPCR trainee communities.

< GPCR News < GPCRs in Oncology and Immunology A virally encoded GPCR drives glioblastoma through feed-forward News Coming soon Become a Contributor Classified GPCR News Call for GPCR papers GPCR Industry News Adhesion GPCRs GPCR Events, Meetings, and Webinars Reviews, GPCRs, and more GPCR Binders, Drugs, and more Methods & Updates in GPCR Research GPCRs in Neuroscience GPCRs in Cardiology, Endocrinology, and Taste GPCRs GPCR News and get weekly notifications about the GPCR field Share < Previous Next >

< GPCR News < GPCRs in Oncology and Immunology Deciphering a GPCR-lncRNA-miRNA Nexus: Identification News Coming soon Become a Contributor Classified GPCR News Call for GPCR papers GPCR Industry News Adhesion GPCRs GPCR Events, Meetings, and Webinars Reviews, GPCRs, and more GPCR Binders, Drugs, and more Methods & Updates in GPCR Research GPCRs in Neuroscience GPCRs in Cardiology, Endocrinology, and Taste GPCRs GPCR News and get weekly notifications about the GPCR field Share < Previous Next >

It's specifically designed for organizations to gain visibility in the GPCR community and promote collaborations GPCR has affected you and the field today . GPCR News 1. Binders, Drugs, and More CXCR4 inhibition attenuates calcium oxalate crystal deposition-induced renal Unmasking allosteric-binding sites: novel targets for GPCR drug discovery. lays off staff just three weeks after netting a $55M PIPE Orion and Peptilogics are pursuing AI-driven drug

GPCR Newsletter, August 2022 edition. GPCR Summit 2022 : The program of the 3rd edition of the Dr. GPCR Summit is taking shape. GPCR News 1. Binders, Drugs, and More Therapeutic validation of an orphan G protein-coupled receptor: The case of of psychedelic-induced plasticity Molecular insights into psychedelic drug action AlphaFold2 versus

CINVESTAV , Mexico City, Mexico October 23-25, 2024 Register LOGO CONTEST Rules for the logo contest Design The Consortium must be free to use the design. The contest deadline is June 15th, 2024, 11:59 PM CST (designs received after the deadline will not be considered) Designs or inquiries should be sent to agpcrlogo2024@gmail.com The prize for the selected design will include free registration and more!

GPCR Podcast << Back to podcast list Dr. GPCR Board About Dr. Alexander S. During his Ph.D. with David Gloriam at the Department of Drug Design and Pharmacology in Copenhagen, of Molecular Biology in Cambridge, UK, where he was working on the impact of genetic variations on drug Award” for his work on GPCRs. Dr. Alexander S. GPCR Ecosystem Listen and subscribe where you get your podcasts << Previous Podcast Episode Next Podcast

< GPCR News < GPCRs in Oncology and Immunology Expression prevalence and dynamics of GPCR somatostatin News Coming soon Become a Contributor Classified GPCR News Call for GPCR papers GPCR Industry News Adhesion GPCRs GPCR Events, Meetings, and Webinars Reviews, GPCRs, and more GPCR Binders, Drugs, and more Methods & Updates in GPCR Research GPCRs in Neuroscience GPCRs in Cardiology, Endocrinology, and Taste GPCRs GPCR News and get weekly notifications about the GPCR field Share < Previous Next >

< GPCR News < GPCRs in Oncology and Immunology Drosophila cytokine GBP2 exerts immune responses and regulates News Coming soon Become a Contributor Classified GPCR News Call for GPCR papers GPCR Industry News Adhesion GPCRs GPCR Events, Meetings, and Webinars Reviews, GPCRs, and more GPCR Binders, Drugs, and more Methods & Updates in GPCR Research GPCRs in Neuroscience GPCRs in Cardiology, Endocrinology, and Taste GPCRs GPCR News and get weekly notifications about the GPCR field Share < Previous Next >

< GPCR News < GPCRs in Oncology and Immunology TIPE proteins control directed migration of human T cells News Coming soon Become a Contributor Classified GPCR News Call for GPCR papers GPCR Industry News Adhesion GPCRs GPCR Events, Meetings, and Webinars Reviews, GPCRs, and more GPCR Binders, Drugs, and more Methods & Updates in GPCR Research GPCRs in Neuroscience GPCRs in Cardiology, Endocrinology, and Taste GPCRs GPCR News and get weekly notifications about the GPCR field Share < Previous Next >

GPCR VideoCast << Back to VideoCast list Dr. He has been also studying what aspects of GPCR signaling are regulated in a sex-selective manner and how this can influence drug discovery in the area of neurodegenerative diseases. GPCR About Victoria Rasmussen "Victoria Rasmussen is a graduate fellow in Dr. She is currently working to understand the signaling and degradation of GPCRs in disease states to help

< GPCR News < GPCRs in Oncology and Immunology Gi/o GPCRs drive the formation of actin-rich tunneling News Coming soon Become a Contributor Classified GPCR News Call for GPCR papers GPCR Industry News Adhesion GPCRs GPCR Events, Meetings, and Webinars Reviews, GPCRs, and more GPCR Binders, Drugs, and more Methods & Updates in GPCR Research GPCRs in Neuroscience GPCRs in Cardiology, Endocrinology, and Taste GPCRs GPCR News and get weekly notifications about the GPCR field Share < Previous Next >

GPCR Podcast << Back to podcast list Dr. GPCR Board About Dr. Juan José Fung Dr. Juan José Fung is a Principal Scientist at GPCR Therapeutics, Inc , a drug discovery company focused Brian Kobilka , studying the dimerization of GPCRs. Dr. spent significant time in the industry studying membrane proteins, antibodies, and HTS methods for drug Juan José Fung on the web LinkedIn GPCR Therapeutics Dr.

GPCR Podcast << Back to podcast list Dr. GPCR Board About Dr. with numerous pharma and biotechs in understanding and applying in vitro pharmacology data to advance drug He specializes in kinetic analysis of drug action and is known for applying binding kinetics to the development He guided the in vitro biology efforts of the company for numerous drug discovery campaigns. GPCR Member ResearchGate Dr.

GPCR VideoCast << Back to VideoCast list Dr. Juan José Fung About Dr. Juan José Fung Dr. Juan José Fung is a Principal Scientist at GPCR Therapeutics, Inc , a drug discovery company focused Brian Kobilka , studying the dimerization of GPCRs. Dr. spent significant time in the industry studying membrane proteins, antibodies, and HTS methods for drug Juan José Fung on the web LinkedIn GPCR Therapeutics Dr.

GPCR Podcast << Back to podcast list Dr. GPCR Board About Dr. Marta Filizola Dr. into the structure, dynamics, and function of important classes of membrane proteins and prominent drug targets, including G protein-coupled receptors (GPCRs), transporters, channels, and 3 integrins. To this end, her lab uses several computational structural biology tools and rational drug design approaches GPCR Ecosystem Listen and subscribe where you get your podcasts << Previous Podcast Episode Next Podcast

< GPCR News < GPCRs in Oncology and Immunology miR-19a may function as a biomarker of oral squamous cell GPCR News Call for GPCR papers GPCR Industry News Adhesion GPCRs GPCR Events, Meetings, and Webinars Reviews, GPCRs, and more GPCR Binders, Drugs, and more Methods & Updates in GPCR Research GPCRs in Neuroscience insights into GPCR function GPCR Activation and Signaling More from Dr. GPCR News and get weekly notifications about the GPCR field Share < Previous Next >

GPCR Podcast << Back to podcast list Dr. He currently leads a team that provides a mechanistic understanding of small molecule drug candidates Brian has contributed to the discovery or development of 5 marketed drugs through his work spanning molecular , biochemical, cellular, and in vivo assessment of drug candidates in many different physiological systems He continues to pioneer in drug discovery studying GPCRs and other target classes.